275 related articles for article (PubMed ID: 22612999)
41. Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer.
Wang KJ; Wang C; Dai LH; Yang J; Huang H; Ma XJ; Zhou Z; Yang ZY; Xu WD; Hua MM; Lu X; Zeng SX; Wang HQ; Zhang ZS; Cheng YQ; Liu D; Tian QQ; Sun YH; Xu CL
Clin Cancer Res; 2019 Feb; 25(3):1070-1086. PubMed ID: 30397177
[TBL] [Abstract][Full Text] [Related]
42. Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.
Chen Y; Huang Y; Reiberger T; Duyverman AM; Huang P; Samuel R; Hiddingh L; Roberge S; Koppel C; Lauwers GY; Zhu AX; Jain RK; Duda DG
Hepatology; 2014 Apr; 59(4):1435-47. PubMed ID: 24242874
[TBL] [Abstract][Full Text] [Related]
43. Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.
Kawai T; Yasuchika K; Ishii T; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Mizumoto M; Hatano E; Uemoto S
Clin Cancer Res; 2015 Jul; 21(13):3081-91. PubMed ID: 25820415
[TBL] [Abstract][Full Text] [Related]
44. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
45. Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy.
Shen S; Sun CY; Du XJ; Li HJ; Liu Y; Xia JX; Zhu YH; Wang J
Biomaterials; 2015 Nov; 70():71-83. PubMed ID: 26302232
[TBL] [Abstract][Full Text] [Related]
46. G protein-coupled receptor 87 (GPR87) promotes the growth and metastasis of CD133⁺ cancer stem-like cells in hepatocellular carcinoma.
Yan M; Li H; Zhu M; Zhao F; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
PLoS One; 2013; 8(4):e61056. PubMed ID: 23593389
[TBL] [Abstract][Full Text] [Related]
47. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
[TBL] [Abstract][Full Text] [Related]
48. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer.
Wang X; Cao Y; Zhang S; Chen Z; Fan L; Shen X; Zhou S; Chen D
Oncotarget; 2017 May; 8(22):36149-36160. PubMed ID: 28193907
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
[TBL] [Abstract][Full Text] [Related]
50. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells.
Chao C; Carmical JR; Ives KL; Wood TG; Aronson JF; Gomez GA; Djukom CD; Hellmich MR
Lab Invest; 2012 Mar; 92(3):420-36. PubMed ID: 22157717
[TBL] [Abstract][Full Text] [Related]
51. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
52. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
53. Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.
Benzoubir N; Mussini C; Lejamtel C; Dos Santos A; Guillaume C; Desterke C; Samuel D; Bréchot C; Bourgeade MF; Guettier C
PLoS One; 2015; 10(6):e0130559. PubMed ID: 26110787
[TBL] [Abstract][Full Text] [Related]
54. Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer.
Mao TL; Fan KF; Liu CL
Gene Ther; 2017 Oct; 24(10):621-629. PubMed ID: 28753202
[TBL] [Abstract][Full Text] [Related]
55. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
56. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche.
Kim M; Koh YJ; Kim KE; Koh BI; Nam DH; Alitalo K; Kim I; Koh GY
Cancer Res; 2010 Dec; 70(24):10411-21. PubMed ID: 21056990
[TBL] [Abstract][Full Text] [Related]
57. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.
Zhang R; Pan X; Huang Z; Weber GF; Zhang G
PLoS One; 2011; 6(8):e23831. PubMed ID: 21909361
[TBL] [Abstract][Full Text] [Related]
58. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
[TBL] [Abstract][Full Text] [Related]
59. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K
PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706
[TBL] [Abstract][Full Text] [Related]
60. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
